What are the possible causes of patchy ground-glass opacities in the upper lobes with bronchial wall thickening on CT?

Differential Diagnosis of Patchy Ground-Glass Opacities in Upper Lobes with Bronchial Wall Thickening

The combination of patchy ground-glass opacities in the upper lobes with bronchial wall thickening should prompt immediate consideration of hypersensitivity pneumonitis (HP), organizing pneumonia (OP/COP), and respiratory bronchiolitis-interstitial lung disease (RB-ILD), with HP being the most critical diagnosis to exclude given its potential for progression to irreversible fibrosis if exposure continues.

Primary Diagnostic Considerations

Hypersensitivity Pneumonitis (Most Important)

The upper lobe predominance with bronchial wall thickening is highly characteristic of HP 1, 2. Key distinguishing features include:

• Centrilobular nodules of ground-glass attenuation (often subtle but pathognomonic when present)
• Three-density pattern (mosaic attenuation with areas of ground-glass, normal lung, and decreased attenuation) 2
• Air trapping on expiratory imaging, often in a lobular distribution
• Middle and upper lobe predominance with absence of honeycombing favors HP over idiopathic pulmonary fibrosis 3

Critical pitfall: HP can progress to irreversible fibrosis if antigen exposure continues. The upper lobe distribution with bronchial wall thickening should trigger aggressive investigation for environmental or occupational exposures (birds, mold, hot tubs, agricultural exposures) 1, 2.

Cryptogenic Organizing Pneumonia (COP)

COP characteristically demonstrates patchy consolidation and ground-glass opacities in a peribronchial pattern 4. Important features:

• Subacute presentation (typically <3 months of symptoms)
• Migratory nature of opacities on serial imaging
• Perilobular opacities and reversed halo (atoll) sign may be present 4
• Responds dramatically to corticosteroids but relapses are common 4

Key distinction: While COP can involve upper lobes, the peribronchial distribution pattern with bronchial wall thickening fits well. However, many cases are secondary to underlying conditions (rheumatoid arthritis, polymyositis, drugs), so exclude these causes 4.

Respiratory Bronchiolitis-Interstitial Lung Disease (RB-ILD)

In heavy smokers, RB-ILD presents with:

• Ground-glass opacities and centrilobular nodules 4
• Marked bronchial wall thickening 4
• Upper and mid-lung predominance
• Minimal emphysema may be present 4

Smoking history is essential - this diagnosis requires active or recent heavy tobacco use 4.

Secondary Considerations

Acute Interstitial Pneumonia (AIP)

In the early exudative phase, AIP shows bilateral patchy ground-glass opacities 4. However:

• Typically presents with rapidly progressive hypoxemia (not subacute)
• Mortality exceeds 50% 4
• Usually has dependent lung consolidation, not primarily upper lobe
• This is a diagnosis of exclusion requiring exclusion of ARDS with known cause 4

Pleuroparenchymal Fibroelastosis (PPFE)

PPFE specifically affects upper lobes with irregular pleural-based opacities 4. However, this represents established fibrosis with parenchymal distortion, not primarily ground-glass opacities.

Infectious/Inflammatory Causes

• Viral pneumonias (influenza, COVID-19, CMV): Can produce ground-glass opacities but typically have more diffuse distribution 5, 6
• Aspiration pneumonitis: Chemical aspiration can cause ground-glass opacities and consolidations, but history of aspiration event is key 7
• Chronic eosinophilic pneumonia: Presents with peripheral (not peribronchial) ground-glass opacities and consolidations 8

Diagnostic Algorithm

Step 1: Obtain detailed exposure history

• Occupational exposures (birds, mold, chemicals)
• Home environment (humidifiers, hot tubs, water damage)
• Medications and supplements
• Smoking history (pack-years)

Step 2: Assess clinical presentation timeline

• Acute (<1 week): Consider infection, aspiration, acute HP
• Subacute (weeks to 3 months): COP, subacute HP
• Chronic (>3 months): Chronic HP, RB-ILD

Step 3: Review CT features systematically

• Look for centrilobular nodules (strongly suggests HP) 1, 2
• Assess for mosaic attenuation/air trapping on expiratory images (HP) 2
• Evaluate for migratory pattern on prior imaging (COP) 4
• Check for reversed halo sign (suggests COP) 4

Step 4: Obtain bronchoalveolar lavage (BAL)

• Lymphocytosis >30% strongly supports HP 1
• High macrophage count (>90%) suggests RB-ILD 4

Step 5: Consider lung biopsy if diagnosis remains uncertain

• Transbronchial biopsy may show features of HP or OP 1
• Surgical lung biopsy reserved for cases where diagnosis impacts management and less invasive testing is non-diagnostic

Critical Management Implications

For HP: Immediate antigen identification and avoidance is paramount - continued exposure leads to irreversible fibrosis with poor prognosis 1, 2. This takes precedence over corticosteroid therapy.

For COP: Oral corticosteroids produce excellent response in most patients, but must exclude secondary causes (connective tissue disease, drugs) before labeling as cryptogenic 4.

For RB-ILD: Smoking cessation is the primary intervention 4.

The upper lobe predominance with bronchial wall thickening makes HP the most critical diagnosis to pursue aggressively, as it is the only one where specific intervention (antigen avoidance) can prevent progression to fatal fibrotic lung disease 1, 2.